1) Wigmore TJ, Mohammed K, Jhanji S:Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery:a retrospective analysis. Anesthesiology 124:69-79, 2016
2) Woo JH, Baik HJ, Kim CH et al:Effect of propofol and desflurane on immune cell populations in breast cancer patients:a randomized trial. J Korean Med Sci 30:1503-1508, 2015
3) Likhvantsev VV, Landoni G, Levikov DI et al:Sevoflurane versus total intravenous anesthesia for isolated coronary artery bypass surgery with cardiopulmonary bypass:a randomized trial. J Cardiothorac Vasc Anesth 2016
4) Egawa J, Inoue S, Nishiwada T et al:Effects of anesthetics on early postoperative cognitive outcome and intraoperative cerebral oxygen balance in patients undergoing lung surgery:a randomized clinical trial. Can J Anaesth 63:1101-1169, 2016
5) Wang X, Wang T, Tian Z et al:Asleepawake-asleep regimen for epilepsy surgery:a prospective study of target-controlled infusion versus manually controlled infusion technique. J Clin Anesth 32:92-100, 2016
6) Louvet N, Rigouzzo A, Sabourdin N et al:Bispectral index under propofol anesthesia in children:a comparative randomized study between TIVA and TCI. Paediatr Anaesth 26:899-908, 2016
7) Franzen D, Bratton DJ, Clarenbach CF et al:Target-controlled versus fractionated propofol sedation in flexible bronchoscopy:A randomized noninferiority trial. Respirology 21:1445-1451, 2016
8) Itakura S, Masui K, Kazama T:Rapid infusion of hydroxyethyl starch 70/0.5 but not acetate Ringer's solution decreases the plasma concentration of propofol during target-controlled infusion. Anesthesiology 125:304-312, 2016
9) Sitsen E, Olofsen E, Lesman A et al:Epidural blockade affects the pharmacokinetics of propofol in surgical patients. Anesth Analg 122:1341-1349, 2016
10) Zhao XN, Ran JH, Bajracharya AR et al:Effect of different doses of dexmedetomidine on median effective concentration of propofol for anesthesia induction:a randomized controlled trial. Eur Rev Med Pharmacol Sci 20:3134-3143, 2016
11) Liu T, Qin M, Li W et al:Effects of a single dose dexmedetomidine on surgical field visibility during middle ear microsurgery:a randomized study. Otol Neurotol 37:680-684, 2016
12) Li YY, Ge DJ, Li JY et al:Sex differences in the morphine-sparing effects of intraoperative dexmedetomidine in patientcontrolled analgesia following general anesthesia:a consort-prospective, randomized, controlled clinical trial. Medicine(Baltimore)95:e3619, 2016
13) Qiao H, Chen J, Li W et al:Intranasal atomised dexmedetomidine optimises surgical field visualisation with decreased blood loss during endoscopic sinus surgery:a randomized study. Rhinology 54:38-44, 2016
14) Wu X, Hang LH, Wang H et al:Intranasally administered adjunctive dexmedetomidine reduces perioperative anesthetic requirements in general anesthesia. Yonsei Med J 57:998-1005, 2016
15) Gupta M, Gupta P, Singh DK:Effect of 3 different doses of intrathecal dexmedetomidine (2.5 microg, 5 microg, and 10 microg) on subarachnoid block characteristics:a prospective randomized double blind dose-response trial. Pain Physician 19:E411-E420, 2016
16) Qi X, Chen D, Li G et al:Comparison of intrathecal dexmedetomidine with morphine as adjuvants in Cesarean sections. Biol Pharm Bull 39:1455-1460, 2016
17) Bharti N, Sardana DK, Bala I:The analgesic efficacy of dexmedetomidine as an adjunct to local anesthetics in supraclavicular brachial plexus block:a randomized controlled trial. Anesth Analg 121:1655-1660, 2015
18) Abdallah FW, Dwyer T, Chan VW et al:IV and perineural dexmedetomidine similarly prolong the duration of analgesia after interscalene brachial plexus block:a randomized, three-arm, triple-masked, placebo-controlled trial. Anesthesiology 124:683-695, 2016
19) Miles LF, Joshi KR, Ogilvie EH et al:General anaesthesia vs. conscious sedation for transfemoral aortic valve implantation:a single UK centre before-and-after study. Anaesthesia 71:892-900, 2016
20) Palermo C, Degnan M, Candiotti K et al:Monitored anesthesia care versus general anesthesia:Experience with the Medtronic CoreValve. J Cardiothorac Vasc Anesth 30:1234-1237, 2016
21) Khalil M, Al-Agaty A, Asaad O et al:A comparative study between propofol and dexmedetomidine as sedative agents during performing transcatheter aortic valve implantation. J Clin Anesth 32:242-247, 2016
22) Servatius H, Hofeler T, Hoffmann BA et al:Propofol sedation administered by cardiologists for patients undergoing catheter ablation for ventricular tachycardia. Europace 18:1245-1251, 2016
23) Goneppanavar U, Magazine R, Periyadka Janardhana B et al:Intravenous dexmedetomidine provides superior patient comfort and tolerance compared to intravenous midazolam in patients undergoing flexible bronchoscopy. Pulm Med 2015:727530, 2015
24) Yuan F, Fu H, Yang P et al:Dexmedetomidine-fentanyl versus propofol-fentanyl in flexible bronchoscopy:A randomized study. Exp Ther Med 12:506-512, 2016
25) Lodenius A, Ebberyd A, Hardemark Cedborg A et al:Sedation with dexmedetomidine or propofol impairs hypoxic control of breathing in healthy male volunteers:A nonblinded, randomized crossover study. Anesthesiology 125:700-715, 2016
26) Dong D, Peng X, Liu J et al:Morbid obesity alters both pharmacokinetics and pharmacodynamics of propofol:dosing recommendation for anesthesia induction. Drug Metab Dispos 44:1579-1583, 2016
27) El-Baraky IA, Abbassi MM, Marei TA et al:Obesity does not affect propofol pharmacokinetics during hypothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth 30:876-883, 2016
28) Cortinez LI, Anderson BJ, Holford NH et al:Dexmedetomidine pharmacokinetics in the obese. Eur J Clin Pharmacol 71:1501-1508, 2015
29) Short TG, Hannam JA, Laurent S et al:Refining target-controlled infusion:an assessment of pharmacodynamic targetcontrolled infusion of propofol and remifentanil using a response surface model of their combined effects on bispectral index. Anesth Analg 122:90-97, 2016
30) Wiczling P, Bieda K, Przybylowski K et al:Pharmacokinetics and pharmacodynamics of propofol and fentanyl in patients undergoing abdominal aortic surgerya study of pharmacodynamic drug-drug interactions. Biopharm Drug Dispos 37:252-263, 2016